• Poster

Lapatinib Plus Trastuzumab Versus Lapatinib Monotherapy inTrastuzumab-Refractory ErbB2+ Metastatic Breast Cancer Patients: Quality of Life Assessment

Citation

Wu, Y., Burstein, H., Blackwell, K. M., Storniolo, A., Rugo, H., Amonkar, M., ... O'Shaughnessy, J. (2008, September). Lapatinib Plus Trastuzumab Versus Lapatinib Monotherapy inTrastuzumab-Refractory ErbB2+ Metastatic Breast Cancer Patients: Quality of Life Assessment. Presented at 33rd European Society for Medical Oncology Congress, .

Abstract